24 [17] D. G. Altman, K. F. Schulz, D. Moher et al., “The revised CON- SORT statement for reporting randomized trials: explanation and elaboration,” Annals of Internal Medicine, vol. 134, no. 8, pp. 663–694, 2001. [18] H. MacPherson, A. White, M. Cummings, K. Jobst, K. Rose, and R. Niemtzow, “Standards for Reporting Interventions in Controlled Trials of Acupuncture: the STRICTA recommen- dations,” Acupuncture in Medicine, vol. 20, no. 1, pp. 22–25, 2002. [19] C. Begg, M. Cho, S. Eastwood et al., “Improving the quality of reporting of randomized controlled trials: the CONSORT statement,” Journal of the American Medical Association, vol. 276, no. 8, pp. 637–639, 1996. [20] D. Moher, A. Jones, and L. Lepage, “Use of the CONSORT statement and quality of reports of randomized trials,” Journal of the American Medical Association, vol. 285, no. 15, pp. 1992– 1995, 2001. [21] P. J. Devereaux, B. J. Manns, W. A. Ghali, H. Quan, and G. H. Guyatt, “The reporting of methodological factors in ran- domized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist,” Controlled Clinical Trials, vol. 23, no. 4, pp. 380–388, 2002. [22] S. George, M. J. Schell, F. C. Detterbeck, and M. A. Socinski, “Adjuvant chemotherapy for resected non-small cell carci- noma of the lung: why we still don’t know,” Oncologist, vol. 3, no. 1, pp. 35–44, 1998. [23] L. P. Rios, A. Odueyungbo, M. O. Moitri, M. O. Rahman, and L. Thabane, “Quality of reporting of randomized controlled trials in general endocrinology literature,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 3810–3816, 2008. [24] G. Wang, B. Mao, Z.-Y. Xiong et al., “The quality of report- ing of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China,” Clinical Therapeutics, vol. 29, no. 7, pp. 1456–1467, 2007. [25] D. B. Hogan, B. Goldlist, G. Naglie, and C. Patterson, “Com- parison studies of cholinesterase inhibitors for Alzheimer’s disease,” Lancet Neurology, vol. 3, no. 10, pp. 622–626, 2004. [26] L. C. Holdcraft, N. Asseﬁ, and D. Buchwald, “Complementary and alternative medicine in ﬁbromyalgia and related syn- dromes,” Best Practice and Research: Clinical Rheumatology, vol. 17, no. 4, pp. 667–683, 2003. [27] R. Agha, D. Cooper, and G. Muir, “The reporting quality of randomised controlled trials in surgery: a systematic review,” International Journal of Surgery, vol. 5, no. 6, pp. 413–422, 2007. [28] A. Khan, S. R. Khan, R. M. Leventhal, K. R. R. Krishnan, and J. M. Gorman, “An application of the revised CONSORT standards to FDA summary reports of recently approved antidepressants and antipsychotics,” Biological Psychiatry, vol. 52, no. 1, pp. 62–67, 2002. [29] D. Moher, K. Soeken, M. Sampson, L. Ben-Porat, and B. Berman, “Assessing the quality of reports of systematic reviews in pediatric complementary and alternative medicine,” BMC Pediatrics, vol. 2, article 3, 2002. [30] R. W. Scherer and B. Crawley, “Reporting of randomized clinical trial descriptors and use of structured abstracts,” Journal of the American Medical Association, vol. 280, no. 3, pp. 269–272, 1998. Evidence-Based Complementary and Alternative Medicine [31] S. P. Balasubramanian, M. Wiener, Z. Alshameeri, R. Tiru- voipati, D. Elbourne, and M. W. Reed, “Standards of reporting of randomized controlled trials in general surgery: can we do better?” Annals of Surgery, vol. 244, no. 5, pp. 663–667, 2006. [32] S. P. Chauhan, V. Berghella, M. Sanderson, D. Siddiqui, N. W. Hendrix, and E. F. Magann, “Randomized clinical trials behind levela recommendations in obstetric practice bulletins: compliance with CONSORT statement,” American Journal of Perinatology, vol. 26, no. 1, pp. 69–80, 2009. [33] X. M. Liu, M. M. Zhang, and L. Du, “Quality of methodology and reporting of randomized controlled trials of acupuncture for obesity,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 26, no. 2, pp. 192–194, 2004. [34] S. L. Prady, S. J. Richmond, V. M. Morton, and H. MacPher- son, “A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials,” PLoS ONE, vol. 3, no. 2, article e1577, 2008. [35] “NIH Consensus Conference. Acupuncture,” Journal of the American Medical Association, vol. 280, no. 17, pp. 1518–1524, 1998. [36] R. Hammerschlag, R. Milley, A. P. Colbert et al., “Randomized controlled trials of acupuncture, 1997–2002: pilot test of a CONSORT and STRICTA based quality of reporting instru- ment,” Journal of Alternative and Complementary Medicine, vol. 10, pp. 203–204, 2004. [37] World Health Organization, “Acupuncture: review and analy- sis of reports on controlled clinical trials,” 1–87, 2003. [38] H. D. Clark, G. A. Wells, C. Hue¨t et al., “Assessing the quality of randomized trials: reliability of the Jadad scale,” Controlled Clinical Trials, vol. 20, no. 5, pp. 448–452, 1999. [39] S. Hopewell, D. G. Altman, D. Moher, and K. F. Schulz, “Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal ’Instructions to Authors’,” Trials, vol. 9, article 20, 2008. [40] K. Uetani, T. Nakayama, H. Ikai, N. Yonemoto, and D. Moher, “Quality of reports on randomized controlled trials conducted in Japan: evaluation of adherence to the CONSORT statement,” Internal Medicine, vol. 48, no. 5, pp. 307–313, 2009. [41] D. Zhang, P. Yin, N. Freemantle, R. Jordan, N. Zhong, and K. K. Cheng, “An assessment of the quality of randomised controlled trials conducted in China,” Trials, vol. 9, article 22, 2008. [42] L. Xu, J. Li, M. Zhang, C. Ai, and L. Wang, “Chinese authors do need CONSORT: reporting quality assessment for ﬁve leading Chinese medical journals,” Contemporary Clinical Trials, vol. 29, no. 5, pp. 727–731, 2008. [43] D. G. Altman, K. F. Schulz, D. Moher et al., “The revised CON- SORT statement for reporting randomized trials: explanation and elaboration,” Clinical Evaluation, vol. 30, pp. 163–208, 2002. [44] D. G. Altman, K. F. Schulz, D. Moher et al., “The revised CON- SORT statement for reporting randomized trials: explanation and elaboration,” Chinese Journal of Evidence-Based Medicine, vol. 5, pp. 712–714, 2005 (Chinese). [45] H. Lee, J. Park, J. Seo, H. Park, and H. Lee, “Standards for Reporting Interventions in Controlled Trials of Acupuncture: the STRICTA recommendations,” Journal of Korean Society for Acupuncture and Moxibustion, vol. 19, pp. 134–154, 2002. [46] X. Liu, M. Zhang, and H. Liu, “Improving the quality of reporting of acupuncture controlled trials by using CON- SORT and STRICTA,” Chinese Acupuncture and Moxibustion, vol. 23, pp. 699–701, 2008.